Clinical Trial Update: Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial update investigates abdominal radiation plus docetaxel for recurrent or persistent advanced ovarian, fallopian tube, or primary peritoneal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | Phase 1 | Status: COMPLETED